The development and validation of non-animal testing methods is accelerating, with organ-on-chip, organoid, and in silico approaches offering increasingly accurate predictions that reduce the need for animal experiments.
Every animal testing alternative that achieves regulatory validation replaces animal welfare costs with scientifically equivalent or superior human-relevant data. The welfare benefit is direct and immediate — animals that would have been used in replaced procedures are not subjected to experimental harm. Investment in alternatives development is therefore one of the most direct ways to prevent laboratory animal welfare harm at scale, with each successful validation multiplying benefits across the industry that adopts the method.